Mikael Cohen
University of Nice Sophia Antipolis
Publications 94
Published on Dec 1, 2019in Journal of Neuroinflammation5.70
Alvaro Cobo-Calvo1
Estimated H-index: 1
(French Institute of Health and Medical Research),
Maria Sepúlveda12
Estimated H-index: 12
(University of Barcelona)
+ 24 AuthorsDamien Biotti7
Estimated H-index: 7
BACKGROUND:Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) are related to several acquired demyelinating syndromes in adults, but the therapeutic approach is currently unclear. We aimed to describe the response to different therapeutic strategies in adult patients with relapsing MOG-Ab-associated disease. METHODS: This is a retrospective study conducted in France and Spain including 125 relapsing MOG-Ab patients aged ≥ 18 years. First, we performed a survival analysis to investigate the ...
Published on Sep 20, 2019in European Journal of Neurology4.39
Elisabeth Maillart9
Estimated H-index: 9
Pierre Labauge34
Estimated H-index: 34
(University of Montpellier)
+ 16 AuthorsThibault Moreau32
Estimated H-index: 32
Published on Apr 23, 2019in Journal of Neurology4.20
Xavier Ayrignac14
Estimated H-index: 14
(University of Montpellier),
Valérie Rigau21
Estimated H-index: 21
(University of Montpellier)
+ 27 AuthorsNicolas Collongues22
Estimated H-index: 22
(UDS: University of Strasbourg)
Background The diagnosis of atypical inflammatory demyelinating lesions can be difficult. Brain biopsy is often required to exclude neoplasms. Moreover, the relationship between these lesions and multiple sclerosis and NMOSD is not clear.
Published on Jul 1, 2019in Neuroimmunology and Neuroinflammation
M. Levraut , Mikael Cohen9
Estimated H-index: 9
+ 8 AuthorsNihal Martis3
Estimated H-index: 3
Objective Meningeal involvement in Immunoglobulin G (IgG)-4-related disease is rare and only described in case reports and series. Because a review into the disease is lacking, we present 2 cases followed by a literature review of IgG4-related hypertrophic pachymeningitis (IgG4-HP). Methods Two IgG4-HP cases were reported, one involving the spinal cord and responding to surgical management and a second involving the brain and responding to Rituximab therapy. We then review clinical cases and cas...
Published on Jun 1, 2019in Revue Neurologique2.18
Heloise Joly2
Estimated H-index: 2
Mikael Cohen9
Estimated H-index: 9
+ 1 AuthorsChristine Lebrun-Frenay16
Estimated H-index: 16
Published on May 31, 2019in Multiple Sclerosis Journal5.65
Jonathan Ciron7
Estimated H-index: 7
(University of Toulouse),
Alvaro Cobo-Calvo1
Estimated H-index: 1
(French Institute of Health and Medical Research)
+ 29 AuthorsDavid Laplaud12
Estimated H-index: 12
Published on Apr 1, 2019in Revue Neurologique2.18
Nicolas Capet , Heloise Joly2
Estimated H-index: 2
+ 4 AuthorsChristine Lebrun-Frenay16
Estimated H-index: 16
Introduction L’alexithymie ou l’absence de mot pour exprimer les emotions est un trouble dont la prevalence peut s’elever jusqu’a 53 % dans la sclerose en plaques (SEP). Peu d’etudes d’imagerie ont ete menees pour expliquer sa frequence dans la maladie. Objectifs Rechercher une association entre alexithymie et les mesures d’atrophie cerebrale pour les differents phenotypes de SEP. Patients et methodes Au total, 81 patients (16 CIS, 27 RR, 21 SP, 17 PP) ont ete testes avec l’echelle TAS pour mesu...